Showing results 5 to 9 of 9
< previous
Title | Author(s) | Issue Date | |
---|---|---|---|
1-Apr-2022 | |||
2021 | |||
Short interfering RNA JNJ-3989 combination therapy in chronic hepatitis B (CHB) shows potent reduction of all viral markers but no correlate was identified for HBsAg reduction and baseline factors Proceeding/Conference:APASL 2022, Seoul, Korea, 30 Mar - 3 Apr 2022. Hepatology International | 2022 | ||
2020 | |||
Viral sequence analysis of not-currently treated (NCT) chronic hepatitis b (CHB) patients enrolled in the reef-1 study and impact of baseline nucleotide polymorphisms in the small interfering rna (siRNA) JNJ-3989 trigger target regions on viral antigen declines Proceeding/Conference:The Liver Meeting 2022: American Association for the Study of Liver Diseases (AASLD) (04/11/2022-08/11/2022, Washington, USA) | 31-Oct-2022 |